Ligand · EIO
EIO · (3R)-4-[6-{1-[diamino(hydroxy)-lambda~4~-sulfanyl]cyclopropyl}-2-(methylsulfanyl)pyrimidin-4-yl]-3-methylmorpholine
EIO, (3R)-4-[6-{1-[diamino(hydroxy)-lambda~4~-sulfanyl]cyclopropyl}-2-(methylsulfanyl)pyrimidin-4-yl]-3-methylmorpholine (C13 H20 N5 O2 S2 +1, 342.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every…
- Component
- EIO
- Formula
- C13 H20 N5 O2 S2 +1
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
EIO in 2 structures; the first of them:
- 7T36 · Crystal structure of the tandem bromodomain (BD1 and BD2) of human TAF1 bound to ZS1-322 · EIO A1701 · binds TRP1526, PRO1527, PHE1528, HIS1530, PRO1531, VAL1532, ASN1533, PHE1536 and 5 more
- 7T36 · Crystal structure of the tandem bromodomain (BD1 and BD2) of human TAF1 bound to ZS1-322 · EIO A1701 · binds TRP1526, PRO1527, PHE1528, HIS1530, PRO1531, VAL1532, ASN1533, PHE1536 and 4 more
Residues it binds most
TYR 2, ASN 2, PHE 2, PRO 2, VAL 2, HIS 2, TRP 2 (residue and the binding sites it lines).
Found with
- EDO · 1,2-ethanediol
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.